Chronic Illness: Certain chronic diseases and conditions can deplete glutathione levels due to increased oxidative stress and inflammation
Farxiga (dapagliflozin) is a prescription drug, commonly taken as a 10 mg oral tablet once daily, to lower blood glucose levels in Type 2 diabetes mellitus, reduce the risk of hospitalization and cardiovascular death in congestive heart failure (CHF), and lower the risk of progression of chronic kidney disease (CKD)
The final dosing schedule may change once the medicine is licensed but it is expected to follow the pattern based on trials data : Start at a low dose, which is gradually increased, similar to how other treatments are prescribed
This is usually a metabolic response and often resolves as intake, weight, and hormone signaling stabilize
Journal of the ASEAN Foundation of Endocrine Societies
Regular check-ups and open communication with qualified healthcare professionals are crucial to meeting your weight loss goals